World Pain Relieving Drug Market 2012-2022 (Related Reports)

World Pain Relieving Drug Market 2012-2022


August 8, 2012
235 Pages - SKU: VSG4881895
License type:
Electronic Access - Single User Fulfilled By Publisher      US $2,633.00
Electronic Access - Departmental 1-5 Users      US $4,648.00
Electronic Access - Global Site License Fulfilled By Publisher      US $10,848.00
Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023
4/7/2014 | published by: Kalorama Information
Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 Kalorama Information's Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 takes a considered look at the pharmaceutical  |  read more...
$3,995.00
Recurrent Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2014
4/15/2014 | published by: GlobalData
Recurrent Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Recurrent Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2014 provides data on the Recurrent Glioblastoma Multiforme (GBM) clinical trial scenario. This  |  read more...
$2,500.00
Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014
4/15/2014 | published by: GlobalData
Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014 provides data on the Recurrent Malignant Glioma clinical trial scenario. This report provides elemental  |  read more...
$2,500.00
Atomic Spectroscopy Market by Technology ( X-Ray Fluorescence / Atomic Absorption / X-Ray Diffraction / ICP-MS ) & by Application ( Food & Beverage / Pharmaceutical / Industrial Chemistry / Biotechnology / Environment ) - Competitive Landscape - Global Fo
4/14/2014 | published by: MarketsandMarkets
Atomic Spectroscopy Market by Technology ( X-Ray Fluorescence / Atomic Absorption / X-Ray Diffraction / ICP-MS ) & by Application ( Food & Beverage / Pharmaceutical / Industrial Chemistry / Biotechnology / Environment ) -  |  read more...
$4,650.00
Cambodia and Laos Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Cambodia and Laos Pharmaceuticals and Healthcare Report Q2 2014 BMI View: Low health and pharmaceutical expenditures will continue to limit the attractiveness of thepharmaceutical market in Cambodia. Given such a profile, the country will present more  |  read more...
$1,295.00
Bahrain Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Bahrain Pharmaceuticals and Healthcare Report Q2 2014 BMI View: This quarter has seen the beginning of a multi-phased plan by the National Health RegulatoryAuthority to significantly reduce medicine prices in the country, signalling a potential advancement  |  read more...
$1,295.00
Denmark Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Denmark Pharmaceuticals and Healthcare Report Q2 2014 BMI View: Although Denmark's pharmaceutical market is relatively small compared to other WesternEuropean countries, the demand for high quality healthcare will remain elevated by an increasing andageing population. This  |  read more...
$1,295.00
Iraq Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Iraq Pharmaceuticals and Healthcare Report Q2 2014 BMI View: The projected growth of Iraq's pharmaceutical market in 2014 and 2015 is linked to an oildriveneconomic expansion, which is dependent on the government's ability to represent and  |  read more...
$1,295.00
Lithuania Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Lithuania Pharmaceuticals and Healthcare Report Q2 2014 BMI View: We expect the Lithuanian pharmaceutical market to post a five-year compound annual growthrate (CAGR) of 4.4%, rising to a value of LTL2.16bn (US$751mn) in 2018. While double-digit  |  read more...
$1,295.00
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2014 BMI View: A better-than-expected outlook for Sri Lanka's economy has led us to upwardly revise ourpharmaceutical and healthcare forecasts. The government has introduced price controls on wholesale andretail  |  read more...
$1,295.00